Dementias Completed Phase 3 Trials for Perphenazine (DB00850)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00009204Serotonergic Pharmacotherapy for Agitation of DementiaTreatment